Molbio Diagnostics IPO launches on August 10, priced between ₹768-807, aiming to raise ₹931 crore for R&D and automation.
Home
News
National
Funds will used to set up own research centre Bengaluru, among other things
The IPO comprises a fresh issue of equity shares aggregating up to ₹200 crore, and an offer for sale of up to 91,66,000 shares by the selling shareholders
Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore…
Molbio Diagnostics raises ₹281.5 crore from anchor investors ahead of its IPO, set to open for subscription on August 10.
The initial public offering price range for Molbio Diagnostics has been established, with a target of raising ₹940 crore.…
Molbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public…
Bio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore…
Bio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently…
